Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Qiangxin Recipe is a Traditional Chinese Medicine (TCM) herbal formulation developed by the Shanghai Hospital of Traditional Chinese Medicine. It is primarily investigated as an adjunctive therapy for patients with chronic heart failure (Stage C) resulting from ischemic heart disease. The formulation is designed to address myocardial fibrosis and improve cardiac function by "tonifying Qi" and "activating blood circulation" according to TCM principles. Clinically, it is evaluated for its ability to reduce N-terminal pro-brain natriuretic peptide (NT-proBNP) levels, improve quality of life, and decrease the incidence of major adverse cardiovascular events (MACE). Its pharmacological mechanism is thought to involve the inhibition of pro-fibrotic pathways, such as the TGF-beta/Smad signaling cascade, thereby limiting pathological ventricular remodeling.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Qiangxin Recipe.